Table 1

Pretreatment characteristics of the patients
Patient ID
 Age
 Weight (kg)
 Genotype
 Gender
 Fibrosis Score Metavir
 ALT (IU/L)
 Day 1 HCV RNA level (IU/Ml)
1
 49
 76
 1a
 1
 4
 74
 1.7E+06
2
 52
 92
 1a
 0
 0
 20
 7.0E+05
3
 52
 92
 1a
 1
 4
 57
 3.4E+06
4
 38
 90
 1a
 1
 0
 52
 1.1E+07
5
 56
 80
 1a
 1
 2
 68
 3.5E+06
6
 47
 106
 1a
 1
 3
 146
 1.1E+07
7
 44
 65
 1b
 1
 2
 127
 1.1E+07
8
 42
 112
 1a
 1
 1
 67
 7.2E+06
9
 52
 78
 1a
 1
 4
 71
 2.3E+06
10
 57
 76
 1b
 0
 2
 68
 7.1E+06
11
 59
 70
 1b
 0
 3
 62
 2.4E+06
12
 56
 109
 1a
 1
 4
 74
 5.8E+06
13
 49
 116
 1a
 1
 2
 44
 5.8E+06
14
 53
 90
 1b
 1
 4
 98
 3.7E+05
15
 51
 61
 1a
 0
 3
 73
 1.8E+06
16
 50
 78
 1a
 1
 3
 99
 1.6E+06
17
 60
 106
 1a
 1
 2
 37
 4.1E+05
18
 45
 114
 1a
 1
 4
 161
 9.0E+05
19
 47
 74
 1b
 1
 3
 117
 4.0E+05
20
 61
 83
 1b
 1
 2
 181
 8.1E+05

Taylor et al. Journal of Translational Medicine 2008 6:66   doi:10.1186/1479-5876-6-66